Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

St. Jude Medical Inc announces CE Mark approval and first use of FlexAbility Ablation Catheter


Tuesday, 22 Jul 2014 08:00am EDT 

St. Jude Medical Inc:Says CE Mark approval and first use of FlexAbility Ablation Catheter, novel ablation technology used by electrophysiologists for the treatment of cardiac arrhythmias.Designed with feedback from physician thought-leaders around world, FlexAbility catheter combines a unique, irrigated flexible catheter tip with a state-of-the-art handle and catheter design.Next-generation flexible tip technology was designed to reduce complications associated with ablation procedures through ability to bend and conform to cardiac anatomy, decreasing amount of pressure distributed to patient's heart wall while simultaneously increasing the stability of therapy delivery.European approval of FlexAbility ablation catheter further strengthens St. Jude Medical's fast-growing ablation technology portfolio. 

Company Quote

64.17
-0.11 -0.17%
4:05pm EDT